Unió Europea - letó - EMA (European Medicines Agency)

accord healthcare s.l.u. - dabigatrāna eteksilāta mesilāts - venous thromboembolism; arthroplasty, replacement - antitrombotiskie līdzekļi - prevention of venous thromboembolic events.

Unió Europea - letó - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unió Europea - letó - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , triple kombinēto terapiju), kā palīglīdzekli, lai diētu un vingrošanu pacientiem nepietiekami kontrolē par to maksimālā pieļaujama devu metformīns un sulfonilurīnvielas pamata. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unió Europea - letó - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - imūnsupresanti - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Letònia - letó - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - mikafungīns - pulveris infūziju šķīduma koncentrāta pagatavošanai - 100 mg

Letònia - letó - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - irinotekāna hidrohlorīda trihidrāts - koncentrāts infūziju šķīduma pagatavošanai - 20 mg/ml

Letònia - letó - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - dutasterīds - kapsula, mīkstā - 0,5 mg

Letònia - letó - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - ritonavīrs - apvalkotā tablete - 100 mg

Letònia - letó - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - olmesartāna medoksomils - apvalkotā tablete - 10 mg

Letònia - letó - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - solifencīna sukcināts - apvalkotā tablete - 10 mg